Health
Safety in mind as Prescient Therapeutics develops next-generation CAR-T platform – Stockhead
Tragedy struck the CAR-T space this month with a US company halting a trial of its lead therapy after the deaths of two patients….
Link copied toclipboard
Tragedy struck the CAR-T space this month with a US company halting a trial of its lead therapy after the deaths of two patients, a sobering reminder of the dangers involved in cell therapy.
The patients reportedly died from immune…
Continue Reading
-
General23 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General22 hours agoJaguar Land Rover in UK pauses shipments to US
-
General19 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General18 hours agoAustralian share market set to dive as threat of US recession grows